Please login to the form below

Not currently logged in
Email:
Password:

Biotechnology

This page shows the latest Biotechnology news and features for those working in and with pharma, biotech and healthcare.

Vertex appoints new commercial lead amid NHS, Orkambi price war

Vertex appoints new commercial lead amid NHS, Orkambi price war

Ludovic brings the leadership skills and functional and geographic experience our growing international organisation needs as we become a leading global biotechnology company.”.

Latest news

More from news
Approximately 5 fully matching, plus 472 partially matching documents found.

Latest Intelligence

  • Made in China Made in China

    major scandal after  ChangSheng Biotechnology was found to have falsified data and produced ineffective vaccines in the country, with another, the Wuhan Institute, found to have also produced substandard vaccines.

  • Reaching the new influencers Reaching the new influencers

    Right now, we’re living through healthcare’s age of accelerations - as evidenced by advances in everything from biotechnology and stem cell research to machine learning and the advent (and approvals)

  • Significant figures Significant figures

    US biotechnology company Insmed enters 2018 in buoyant spirits after a pivotal 12 months that saw its lead product candidate begin to make good on its promise after a shaky start.

  • A unique ecosystem A unique ecosystem

    In today’s globalised world, clusters can provide a great opportunity, bringing together producers, service providers, educational and research institutions and other market players in all areas, including the biotechnology, pharmaceutical

  • Patently unclear? Patently unclear?

    The field of biotechnology, in particular, has a number of such obstacles littering the way for a biotech company which vary from jurisdiction to jurisdiction, meaning that something which may be

More from intelligence
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Lemus comes to the company leveraging over 20 years’of US and international business experience in the pharmaceutical and biotechnology industries having served in executive management and non-executive board roles.

  • Exelixis appoints Andrew Peters to newly created position Exelixis appoints Andrew Peters to newly created position

    California, US-based biotechnology group Exelixis has appointed Andrew Peters as vice president of strategy. ... Commenting on his appointment, Michael Morrissey, president and chief executive officer of Exelixis, said: “Andrew’s extensive experience

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    Prior to his time at Teva as its president of global research and development and chief scientific officer, Hayden founded multiple biotechnology companies including Aspreva Pharmaceuticals.

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition of Francois Nader.

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Mullen has over 30 years’experience leading biotechnology and pharmaceutical organisations on a global scale. ... Katrine Bosley, president and chief executive officer of Editas Medicine, said: “Jim is a renowned leader in the biotechnology industry

More from appointments
Approximately 2 fully matching, plus 107 partially matching documents found.

Latest from PMHub

  • Random42 Partner with MedCity for BioJapan 2018

    Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and biotechnology

  • Random42 Exhibiting at BioCap Conference 2018

    About Random42 . Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and

  • Random42 Exhibiting at BioCap Conference 2018

    About Random42 . Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and

  • PRMA Consulting Ltd

    PRMA Consulting Ltd. PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today.

  • New ICMJE Guidelines and their Impact on Biotech

    New ICMJE Guidelines and their Impact on Biotech. Currently, and over the past several years, I have enjoyed working with smaller biotechnology and pharma companies, many of which are looking to

More from PMHub
Approximately 3 fully matching, plus 113 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics